市場調査レポート

商品コード

1593490

バイオリアクターの市場規模・シェア・成長分析 (材料別、使用段階別、制御方式別、地域別)：産業予測 (2024～2031年)

Bioreactors Market Size, Share, Growth Analysis, By Materials (Glass, Stainless Steel), By Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By Control Type (Manual, and Automated) By Region - Industry Forecast 2024-2031

出版日: 2024年11月08日
発行: SkyQuest
ページ情報: 英文 177 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 766,592円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 896,768円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,026,944円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のバイオリアクターの市場規模は、2022年に約135万米ドルと評価され、2023年の146万米ドルから上昇し、2031年には268万米ドルに達し、予測期間 (2024～2031年) に7.9%のCAGRで成長する、と予測されています。

バイオリアクターの世界市場は、製薬・バイオ医薬品分野での使用増加により、力強い成長を遂げています。バイオリアクターは、特に慢性疾患の治療に使用される生物を制御された条件下で培養するなど、研究開発の手順を進める上で重要な役割を果たしています。モノクローナル抗体に対する需要の高まりと、ワクチン生産に対する政府の資金援助が、市場拡大にさらに拍車をかけています。さらに、使い捨て型バイオリアクターの採用拡大が、コスト効率と柔軟性に優れたソリューションへの業界のシフトを反映して、収益創出に大きく貢献しています。技術進歩はバイオリアクターの機能を強化し、効率と成果を改善する革新的な機能を可能にしました。拡大する製薬・バイオテクノロジー業界と民間組織からの投資の増加は、医薬品開発から工業プロセスまで、バイオリアクターの幅広い用途への依存度の上昇を裏付けています。このように、バイオリアクターは世界の医療の課題解決に不可欠なツールとして位置づけられ、市場成長を牽引しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (MEA)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア (%、2023年)

主要企業プロファイル

Sartorius AG (ドイツ)
Thermo Fisher Scientific Inc. (米国)
General Electric (米国)
Eppendorf AG (ドイツ)
Merck KGaA (ドイツ)
Pall Corporation (米国)
ZETA (インド)
PRaj Hipurity Systems Limited (インド)
Bioengineering AG (スイス)
Infors AG (スイス)
Solaris Biotechnology Srl. (Donaldson Company) (イタリア)
Bbi Biotech (ドイツ)
Shanghai Bailun Biotechnology co., Ltd. (中国)
PBS Biotech Inc. (米国)
CerCell A/S (デンマーク)
GEA Group Aktiengesellschaft (ドイツ)
M+W Group (ドイツ)
Technip S.A. (フランス)
Jacobs Engineering Group Inc. (米国)

Product Code: SQMIG35H2293

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024-2031).

The global bioreactors market is experiencing robust growth, driven by their increasing use in the pharmaceutical and biopharmaceutical sectors. Bioreactors play a critical role in advancing procedures for research and development, particularly in cultivating organisms used to treat chronic illnesses under controlled conditions. The rising demand for monoclonal antibodies and government-backed funding for vaccine production further fuel market expansion. Additionally, the growing adoption of single-use bioreactors significantly contributes to revenue generation, reflecting the industry's shift toward cost-effective and flexible solutions. Technological advancements have enhanced bioreactor capabilities, enabling innovative features that improve efficiency and outcomes. The expanding pharmaceutical and biotechnology industries, coupled with rising investments from private organizations, underscore the growing reliance on bioreactors for diverse applications, from drug development to industrial processes. This convergence of factors positions bioreactors as essential tools in addressing global healthcare challenges while driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioreactors Market Segmental Analysis

Global Bioreactors Market is segmented by Materials, Scale, Usage, Application, Control Type, Suppliers, End-Users and region. Based on Materials, the market is segmented into Glass, Stainless Steel, Single-Use, and Others. Based on Scale, the market is segmented into 5L-20L, 20L-200L, 200L-1500L, and Above 1500L. Based on Application, the market is segmented into Antibodies, Vaccines, Cell Therapies, Others. Based on Usage, the market is segmented into Lab-Scale Production, Pilot-Scale Production, Full-Scale Production, and Others. Based on Control Type, the market is segmented into Manual, and Automated (MFCs). Based on Suppliers, the market is segmented into OEMs (Original Equipment Manufacturers), System Integrators, EPCs (Engineering Procurement and Construction). Based on End User, the market is segmented into R&D Institutes, Contract Research Organizations, Biopharmaceutical Manufacturers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bioreactors Market

The increasing utilization of bioreactors for manufacturing various vaccines, which play a crucial role in mitigating numerous diseases, is significantly driving the growth of the global bioreactors market. The recent outbreak of the COVID-19 pandemic highlighted the critical need for effective vaccine production, leading to a surge in demand for clinical-stage bioreactors. Pharmaceutical companies extensively adopted bioreactors to meet the heightened demand and successfully deliver preventive vaccines to the market. This trend underscores the pivotal role of bioreactors in accelerating vaccine development and production processes, making them indispensable for combating existing and emerging health crises. As a result, the market is witnessing robust growth driven by advancements in bioprocessing technologies and the urgent need for scalable solutions in vaccine manufacturing.

Restraints in the Global Bioreactors Market

The global bioreactors market faces a significant restraint due to the limitations of single-use bioreactors. Despite the availability of various bioreactor types, single-use bioreactors are hindered by their limited capacity and inability to support prolonged operations. These constraints pose substantial challenges, particularly in processes requiring high scalability and extended durations, making them less viable for pharmaceutical and biopharmaceutical companies. Consequently, the adoption of single-use bioreactors has been adversely affected, creating a bottleneck in the market's growth. This limitation highlights the need for advanced bioreactor technologies capable of addressing these challenges while maintaining the benefits of single-use systems, such as cost efficiency and flexibility, to enable broader market expansion.

Market Trends of the Global Bioreactors Market

The global bioreactors market is witnessing significant growth driven by continuous innovations in bioreactor design and processing technologies. Manufacturers are actively developing advanced, cost-efficient bioreactors that enable the large-scale production of various products, enhancing operational efficiency and reducing costs. These technological advancements not only improve bioprocessing capabilities but also offer several advantages, such as higher productivity and streamlined processes, further boosting market demand. The integration of cutting-edge features in bioreactors is contributing to increased adoption across industries, resulting in higher revenue generation and market expansion. This trend underscores the pivotal role of technology in shaping the future of the bioreactors market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Innovation Matrix
Regulatory Analysis
Case Study Analysis
Technology Analysis
Patent Analysis

Bioreactor Market, By Materials

Market Overview
Glass
Stainless Steel
Single-Use
Others

Bioreactor Market, By Scale

Market Overview
5L-20L
20L-200L
200L-1500L
Above 1500L

Bioreactor Market, By Application

Market Overview
Antibodies
Vaccines
Cell Therapies
Others

Bioreactor Market, By Usage

Market Overview
Lab-Scale Production
Pilot-Scale Production
Full-Scale Production
Others

Bioreactor Market, By Control Type

Market Overview
Manual
Automated (MFCs)

Bioreactor Market, By Suppliers

Market Overview
OEMs (Original Equipment Manufacturers)
System Integrators
EPCs (Engineering Procurement and Construction)

Bioreactor Market, By End User

Market Overview
R&D Institutes
Contract Research Organizations
Biopharmaceutical Manufacturers
Others

Bioreactor Market, Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZETA (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRaj Hipurity Systems Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineering AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infors AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solaris Biotechnology Srl. (Donaldson Company) (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bbi Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Bailun Biotechnology co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PBS Biotech Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CerCell A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GEA Group Aktiengesellschaft (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
M+W Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Technip S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jacobs Engineering Group Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バイオリアクターの市場規模・シェア・成長分析 (材料別、使用段階別、制御方式別、地域別)：産業予測 (2024～2031年)

Bioreactors Market Size, Share, Growth Analysis, By Materials (Glass, Stainless Steel), By Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By Control Type (Manual, and Automated) By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

バイオリアクター市場：材料別

バイオリアクター市場：規模別

バイオリアクター市場：用途別

バイオリアクター市場：使用段階別

バイオリアクター市場：制御方式別

バイオリアクター市場：サプライヤー別

バイオリアクター市場：エンドユーザー別

バイオリアクター市場：地域別規模